AI assistant
LEMAITRE VASCULAR INC — Director's Dealing 2025
Dec 10, 2025
31708_dirs_2025-12-10_4ddda8e1-6c14-47eb-94a0-33685bbefab5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2025-12-08
Reporting Person: Jasinski Lawrence J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-08 | Common Stock | M | 2 | — | Acquired | 4776 | Direct |
| 2025-12-08 | Common Stock | M | 3 | — | Acquired | 4779 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | Dividend Equivalent Rights | $ | M | 2 | Disposed | Common Stock (2) | Direct | |
| 2025-12-08 | Dividend Equivalent Rights | $ | M | 3 | Disposed | Common Stock (3) | Direct |
Footnotes
F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.